Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	2068-2069
Number of pages	2
Journal	Journal of Oncology Pharmacy Practice
Volume	26
Issue number	8
DOIs	https://doi.org/10.1177/1078155220967100
Publication status	Published - Dec 2020

Access to Document

@article{9aca530ab4144f4aa353bd4c82c130c1,

title = "Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors",

author = "Banu Cakir",

year = "2020",

month = dec,

doi = "10.1177/1078155220967100",

language = "English",

volume = "26",

pages = "2068--2069",

journal = "Journal of Oncology Pharmacy Practice",

issn = "1078-1552",

publisher = "SAGE Publications Ltd",

number = "8",

}

TY - JOUR

T1 - Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors

AU - Cakir, Banu

PY - 2020/12

Y1 - 2020/12

UR - https://www.scopus.com/pages/publications/85093538050

U2 - 10.1177/1078155220967100

DO - 10.1177/1078155220967100

M3 - Letter

C2 - 33081582

AN - SCOPUS:85093538050

SN - 1078-1552

VL - 26

SP - 2068

EP - 2069

JO - Journal of Oncology Pharmacy Practice

JF - Journal of Oncology Pharmacy Practice

IS - 8

ER -